Picture [LSE] – The Business Web Portal 600x80px
Document › Details

Fluidigm Corporation. (2/14/18). "Press Release: Fluidigm to Participate in Upcoming Health Care Investor Conferences". South San Francisco, CA.

Region Region Boston, MA
  Country United States (USA)
Organisations Organisation Fluidigm Corporation (Nasdaq: FLDM)
  Group Fluidigm (Group)
  Organisation 2 Cowen & Company LLC
  Group Cowen (Group)
Products Product Cowen & Co. Annual Health Care Conference 2018 Boston
  Product 2 BTIG Healthcare Conference 2018 Snowbird UT
Index terms Index term Fluidigm–BTIG: investor conference, 201803 supply service Fluidigm participates in Annual BTIG Healthcare Conference 2018
  Index term 2 Fluidigm–Cowen: investor conference, 201803 supply service Fluidigm presents at Cowen & Co Annual Health Care Conference 2018
Persons Person Linthwaite, S. Christopher (Chris) (Fluidigm 201610– CEO joined 201608 as COO before Thermo Fisher + Life Technologies)
  Person 2 Jog, Vikram (Fluidigm 200802– CFO before XDx CFO + Applera)

Fluidigm Corporation (NASDAQ:FLDM) today announced that the company's management will participate in two upcoming investor conferences.

Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in the fifth annual BTIG Healthcare Conference, focused on medical technology, life sciences, and diagnostic tools, in Snowbird, Utah, on Wednesday, February 28, and Thursday, March 1.

Linthwaite and Jog will also participate in the Cowen and Company 38th Annual Health Care Conference at the Boston Marriott Copley Place in Boston, Massachusetts. Linthwaite will present on Tuesday, March 13, 2018, at 9:20 am ET, with a breakout to follow at 10:00 am ET.

A live webcast of the company's presentation and subsequent replay may be accessed at The webcast will be archived for 90 days following the live presentation.

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

Fluidigm and the Fluidigm logo are trademarks and/or registered trademarks of Fluidigm Corporation.


Fluidigm Corporation

Ana Petrovic
Director, Corporate Development and Investor Relations
650 243 6628 (office)

Record changed: 2018-02-18


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Fluidigm (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px Picture [LSE] – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px